Definitive Healthcare Corp. (DH) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
↓
7.25
↓-89% vs avg
5yr avg: 65.05
30Y Low21.0·High96.4
P/FCF
↓
2.60
↓-94% vs avg
5yr avg: 46.46
30Y Low8.3·High143.5
P/B Ratio
↓
0.26
↓-74% vs avg
5yr avg: 1.01
30Y Low0.7·High1.8
ROE
↓
-28.2%
↑-51% vs avg
5yr avg: -18.7%
30Y Low-46%·High-0%
Debt/EBITDA
↑
11.67
↓-15% vs avg
5yr avg: 13.81
30Y Low8.3·High21.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
DH Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Definitive Healthcare Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 2.6x P/FCF, 94% below the 5-year average of 46.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $96M | $306M | $479M | $1.1B | $1.1B | $2.7B | — | — |
| Enterprise Value | $111M | $320M | $627M | $1.3B | $1.2B | $2.5B | — | — |
| P/E Ratio → | -0.71 | — | — | — | — | — | — | — |
| P/S Ratio | 0.40 | 1.27 | 1.90 | 4.46 | 4.99 | 15.96 | — | — |
| P/B Ratio | 0.26 | 0.81 | 0.79 | 0.93 | 0.75 | 1.77 | — | — |
| P/FCF | 2.60 | 8.26 | 10.46 | 29.33 | 40.78 | 143.49 | — | — |
| P/OCF | 1.79 | 5.69 | 8.24 | 27.21 | 31.23 | 105.18 | — | — |
P/E links to full P/E history page with 30-year chart
DH EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Definitive Healthcare Corp.'s enterprise value stands at 7.3x EBITDA, 89% below its 5-year average of 65.0x. The Healthcare sector median is 14.4x, placing the stock at a 50% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.33 | 2.49 | 5.00 | 5.57 | 15.26 | — | — |
| EV / EBITDA | 7.25 | 21.02 | — | — | 96.43 | 77.69 | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | 8.64 | 13.68 | 32.92 | 45.51 | 137.17 | — | — |
DH Profitability
Margins and return-on-capital ratios measuring operating efficiency
Definitive Healthcare Corp. earns an operating margin of -8.5%. Operating margins have expanded from -131.2% to -8.5% over the past 3 years, signaling improving operational efficiency. A negative ROE of -28.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.9% | 75.9% | 78.3% | 81.1% | 80.9% | 75.5% | 74.2% | 49.7% |
| Operating Margin | -8.5% | -8.5% | -281.8% | -131.2% | -19.8% | -16.4% | -13.4% | -2.5% |
| Net Profit Margin | -57.5% | -57.5% | -163.8% | -80.5% | -3.2% | -31.2% | -44.5% | -42.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -28.2% | -28.2% | -45.7% | -15.1% | -0.5% | -3.9% | -4.4% | -3.0% |
| ROA | -15.2% | -15.2% | -28.3% | -10.3% | -0.3% | -2.7% | -3.0% | -2.1% |
| ROIC | -2.7% | -2.7% | -51.0% | -16.8% | -2.2% | -1.4% | -0.7% | — |
| ROCE | -2.7% | -2.7% | -55.0% | -18.1% | -2.2% | -1.5% | -1.0% | -0.1% |
DH Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Definitive Healthcare Corp. carries a Debt/EBITDA ratio of 11.7x, which is highly leveraged (255% above the sector average of 3.3x). Net debt stands at $14M ($178M total debt minus $164M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.47 | 0.47 | 0.42 | 0.22 | 0.19 | 0.18 | 0.39 | 0.36 |
| Debt / EBITDA | 11.67 | 11.67 | — | — | 21.45 | 8.30 | 10.57 | 14.01 |
| Net Debt / Equity | — | 0.04 | 0.24 | 0.11 | 0.09 | -0.08 | 0.37 | 0.35 |
| Net Debt / EBITDA | 0.93 | 0.93 | — | — | 10.02 | -3.58 | 10.00 | 13.73 |
| Debt / FCF | — | 0.38 | 3.22 | 3.58 | 4.73 | -6.32 | 20.03 | 21.87 |
| Interest Coverage | -17.54 | -17.54 | -41.71 | -19.27 | -2.74 | -1.42 | -0.44 | -0.98 |
DH Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.64x means Definitive Healthcare Corp. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.23x to 1.64x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | 1.64 | 2.30 | 2.23 | 2.94 | 3.61 | 0.72 | 0.52 |
| Quick Ratio | 1.64 | 1.64 | 2.30 | 2.23 | 2.94 | 3.61 | 0.72 | 0.52 |
| Cash Ratio | 1.15 | 1.15 | 1.80 | 1.80 | 2.36 | 3.15 | 0.28 | 0.12 |
| Asset Turnover | — | 0.33 | 0.23 | 0.14 | 0.10 | 0.08 | 0.07 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 78.55 | 77.04 | 86.02 | 96.39 | 95.20 | 102.14 | 106.81 |
DH Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Definitive Healthcare Corp. returns 54.5% to shareholders annually — split between a 3.2% dividend yield and 51.3% buyback yield.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.2% | 1.0% | 1.1% | 1.1% | 1.2% | 0.3% | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | 38.5% | 12.1% | 9.6% | 3.4% | 2.5% | 0.7% | — | — |
| Buyback Yield | 51.3% | 16.2% | 4.7% | 0.0% | 0.0% | 8.7% | — | — |
| Total Shareholder Yield | 54.5% | 17.2% | 5.7% | 1.1% | 1.2% | 9.0% | — | — |
| Shares Outstanding | — | $107M | $117M | $113M | $101M | $97M | $97M | $149M |
Peer Comparison
Compare DH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 DHYou | $96M | -0.7 | 7.3 | 2.6 | 75.9% | -8.5% | -28.2% | -2.7% | 11.7 |
 VEEV | $27B | 30.9 | 28.4 | 19.3 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
 MMSI | $4B | 29.3 | 13.1 | 17.2 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 DOCS | $5B | 23.5 | 21.1 | 19.6 | 90.2% | 39.9% | 22.5% | 20.0% | 0.1 |
 HCAT | $113M | -0.6 | — | — | 48.7% | -51.7% | -58.3% | -32.9% | — |
 PINC | $2B | 128.5 | 21.3 | 7.3 | 73.4% | 0.1% | 1.2% | 0.0% | 2.4 |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 SDGR | $992M | -9.4 | — | 79.7 | 55.7% | -65.2% | -26.3% | -39.4% | — |
 CRM | $179B | 23.9 | 20.0 | 12.4 | 77.7% | 21.5% | 12.4% | 10.9% | 0.8 |
 MSFT | $3.1T | 30.9 | 19.7 | 43.7 | 68.8% | 45.6% | 33.3% | 24.9% | 0.7 |
 SNOW | $53B | -38.9 | — | 47.0 | 67.2% | -30.6% | -53.0% | -43.1% | — |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See DH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DH vs VEEV
Side-by-side business, growth, and profitability comparison vs Veeva Systems Inc..
Start ComparisonDH — Frequently Asked Questions
Quick answers to the most common questions about buying DH stock.
What is Definitive Healthcare Corp.'s P/E ratio?
Definitive Healthcare Corp.'s current P/E ratio is -0.7x. This places it at the 50th percentile of its historical range.
What is Definitive Healthcare Corp.'s EV/EBITDA?
Definitive Healthcare Corp.'s current EV/EBITDA is 7.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 65.0x.
What is Definitive Healthcare Corp.'s ROE?
Definitive Healthcare Corp.'s return on equity (ROE) is -28.2%. The historical average is -14.4%.
Is DH stock overvalued?
Based on historical data, Definitive Healthcare Corp. is trading at a P/E of -0.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Definitive Healthcare Corp.'s dividend yield?
Definitive Healthcare Corp.'s current dividend yield is 3.20%.
What are Definitive Healthcare Corp.'s profit margins?
Definitive Healthcare Corp. has 75.9% gross margin and -8.5% operating margin.
How much debt does Definitive Healthcare Corp. have?
Definitive Healthcare Corp.'s Debt/EBITDA ratio is 11.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.